Yuri Gleba

This inventor holds 33 USPTO granted patents and 15 published patent applications, plus 17 CIPO patents and 26 EPO patents, primarily in Plant Biotechnology. Top assignees: Icon Genetics Gmbh, Nomad Bioscience Gmbh, Bayer Cropscience Nv. Active years: 2008-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuri Gleba. Retrieved from https://idiyas.com/inventor/yuri-gleba

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 33 (Patent Applications = 15)

% Patents Active = 51.5

CIPO Patents = 17 (Patent Applications = 7)

EPO Patents = 26 (Patent Applications = 20)

Average Co-Inventor Count = 4.5

ph-index = 4

Forward Citations = 47(Granted Patents)

Location History:

München, DE (2008 - 2012)
Saale, DE (2014)
Halle, DE (2010 - 2016)
Halle/Saale, DE (2009 - 2018)
Berlin, DE (2018 - 2021)

Company Filing History:

Nomad Bioscience Gmbh

University of Southampton

patents

where one patent can have more than one assignee

Years Active: 2008-2025

Loading Chart...

Areas of Expertise:

Bacteriocins

Transgenic Plants

RNA Virus

Plant Transformation

Gene Expression

Protein Expression

Amplification Vectors

Internal Ribosome Entry Site

EHEC Control

Hybrid Seeds

Nucleic Acid Sequences

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12264183 - Bacteriocins for control of (2025-04-01),

2. 11161886 - Bacteriocins for control of (2021-11-02),

3. 10934553 - Agrobacterium for transient transfection of whole plants (2021-03-02),

4. 10435704 - Method of co-expressing a glycoprotein and a single-subunit olicosaccharyltransferase in a plant (2019-10-08),

5. 10287602 - RNA virus-derived plant expression system (2019-05-14),

6. 10201168 - Colicins for the control of EHEC (2019-02-12),

7. 10052370 - HER2/Neu cancer vaccine (2018-08-21),

8. 9856484 - Plant transformation with in vivo assembly of a trait (2018-01-02),

9. 9267143 - RNA virus-derived plant expression system (2016-02-23),

10. 9228192 - Plant transformation with in vivo assembly of a sequence of interest using a site-specific recombinase (2016-01-05),

11. 8940963 - Production of hetero-oligomeric proteins in plants (2015-01-27),

12. 8624080 - Plant virus-based inducible expression system (2014-01-07),

13. 8604281 - Transgenic plants with controlled distribution of a trait to progeny (2013-12-10),

14. 8597950 - Two-component RNA virus-derived plant expression system (2013-12-03),

15. 8415463 - Potexvirus-derived replicon (2013-04-09),

Title: Yuri Gleba: Pioneering Innovation in the World of Inventions

Introduction: Yuri Gleba, a distinguished inventor based in Halle/Saale, DE, has made significant contributions to the field of inventions. With a total of 32 patents to his name, Gleba's passion for innovation and relentless pursuit of excellence have positioned him as a trailblazer in the industry, inspiring future generations of inventors.

Latest Patents: Gleba's recent patents include groundbreaking inventions such as 'Bacteriocins for control of salmocins,' which are derived from plants and used to prevent infection or contamination with Agrobacterium. Another notable patent is the process for transiently transfecting plants with strain CryX, showcasing his expertise in biotechnology and plant sciences.

Career Highlights: Throughout his career, Yuri Gleba has worked with reputable companies such as Icon Genetics GmbH and Bayer CropScience NV. These collaborations have provided him with the opportunity to further his research and develop innovative solutions in the agricultural and biotechnological sectors.

Collaborations: Gleba has had the privilege of collaborating with esteemed colleagues in the industry, including Victor Klimyuk and Sylvestre Marillonnet. Together, they have worked on various projects aimed at advancing the field of inventions and bringing new ideas to life.

Conclusion: Yuri Gleba's remarkable journey as an inventor underscores his commitment to pushing the boundaries of what is possible through innovation. His impactful work not only showcases his technical expertise but also serves as a beacon of inspiration for aspiring inventors worldwide. Gleba's legacy continues to shape the landscape of inventions, leaving an indelible mark on the industry.

Profile summary based on public USPTO records.